HealthEquity Analysts Cut Their Forecasts After Q4 Results HealthEquity Inc (
NASDAQ: HQY ) beat earnings expectations for Q4, with adjusted EPS of 95 cents. FY2027 guidance raised and analysts maintain ratings.
HealthEquity Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call HealthEquity, Inc. (
NASDAQ: HQY ) to release Q4 earnings on 3/17. Analysts expect earnings of $0.90/share and revenue of $332.82M. Stock rose 1.1% on 3/16.
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.
Nova Stock Up 80% in a Year, so What Should Investors Know About This $194 Million Sale? Nova Ltd. delivers metrology and process control solutions to semiconductor manufacturers worldwide, supporting advanced chip production.
Trex Stock Down 36% as Wasatch Sells Off $63 Million in Shares Trex Company manufactures composite decking and outdoor living products for residential and commercial customers across the U.S.
Valvoline Adds 200 Stores, Grows Sales 11%, but One Fund Still Sold Off $67 Million in Stock This automotive maintenance leader serves global markets with branded quick-lube centers and a broad portfolio of aftermarket products.
Everus Stock Up 100% in a Year as One Fund Discloses New $185 Million Stake Everus Construction Group delivers utility and specialty equipment services to major clients across the Midwest and key metro markets.
HealthEquity Inc (NASDAQ:HQY) Emerges as a Prime Affordable Growth Stock HealthEquity (HQY) exemplifies GARP investing with solid earnings growth, a reasonable valuation, and strong financial health.
HealthEquity Inc (NASDAQ:HQY) Presents a Compelling Growth and Technical Setup HealthEquity (HQY) shows strong earnings growth, high profitability, and a solid balance sheet, now forming a technical setup near key support levels.
This Fund Just Dumped Itron Stock, but Should Long-Term Investors Follow Suit? A sharp rally, a sudden reversal, record cash flow, and one institutional trim -- all raise a bigger question about where Itron fits in a long-term portfolio right now.
Dycom Stock Up 95% in One Year as One Fund Trims Exposure After $1.5 Billion Quarter After a near-doubling in the stock, the real question is whether Dycom’s record backlog and margin expansion can justify staying all-in at these levels.
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back The sale hints at profit-taking in a stock that’s executing operationally but facing tougher questions about durability and valuation.
HealthEquity Inc (NASDAQ:HQY) Reports Q3 Earnings Beat Despite Revenue Miss HealthEquity (HQY) Q3 earnings beat EPS estimates with $1.01, driving stock up. Revenue of $322.2M slightly missed forecasts, but strong profit growth impressed investors.
HEALTHEQUITY INC (NASDAQ:HQY) Presents a Strong Growth and Breakout Profile HealthEquity (HQY) shows strong revenue & earnings growth, high profitability, and a solid balance sheet, now signaling a potential technical breakout.
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades' Stephen Weiss of Short Hills Capital Partners, named Taiwan Semiconductor Manufacturing Company as his final trade.
HEALTHEQUITY INC (NASDAQ:HQY) Presents a Compelling Growth and Breakout Opportunity HealthEquity (HQY) offers a strong growth profile with accelerating earnings and a positive technical breakout setup, blending fundamental and technical analysis.
